Identification of six new susceptibility loci for invasive epithelial ovarian cancer
- PMID: 25581431
- PMCID: PMC4445140
- DOI: 10.1038/ng.3185
Identification of six new susceptibility loci for invasive epithelial ovarian cancer
Abstract
Genome-wide association studies (GWAS) have identified 12 epithelial ovarian cancer (EOC) susceptibility alleles. The pattern of association at these loci is consistent in BRCA1 and BRCA2 mutation carriers who are at high risk of EOC. After imputation to 1000 Genomes Project data, we assessed associations of 11 million genetic variants with EOC risk from 15,437 cases unselected for family history and 30,845 controls and from 15,252 BRCA1 mutation carriers and 8,211 BRCA2 mutation carriers (3,096 with ovarian cancer), and we combined the results in a meta-analysis. This new study design yielded increased statistical power, leading to the discovery of six new EOC susceptibility loci. Variants at 1p36 (nearest gene, WNT4), 4q26 (SYNPO2), 9q34.2 (ABO) and 17q11.2 (ATAD5) were associated with EOC risk, and at 1p34.3 (RSPO1) and 6p22.1 (GPX6) variants were specifically associated with the serous EOC subtype, all with P < 5 × 10(-8). Incorporating these variants into risk assessment tools will improve clinical risk predictions for BRCA1 and BRCA2 mutation carriers.
Figures
References
-
- Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol. 1998;105:493–499. - PubMed
-
- Jervis S, et al. Ovarian cancer familial relative risks by tumour subtypes and by known ovarian cancer genetic susceptibility variants. J Med Genet. 2013 - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- U10 CA180868/CA/NCI NIH HHS/United States
- UG1 CA189867/CA/NCI NIH HHS/United States
- UM1 CA164920/CA/NCI NIH HHS/United States
- 11174/CRUK_/Cancer Research UK/United Kingdom
- 16565/CRUK_/Cancer Research UK/United Kingdom
- 076113/WT_/Wellcome Trust/United Kingdom
- U10 CA180850/CA/NCI NIH HHS/United States
- P50 CA116201/CA/NCI NIH HHS/United States
- U10 CA037517/CA/NCI NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U19-CA148112/CA/NCI NIH HHS/United States
- UM1 CA182910/CA/NCI NIH HHS/United States
- UL1 TR000005/TR/NCATS NIH HHS/United States
- R01 CA140323/CA/NCI NIH HHS/United States
- R01 CA176785/CA/NCI NIH HHS/United States
- P50 CA159981/CA/NCI NIH HHS/United States
- RC4 CA153828/CA/NCI NIH HHS/United States
- R01 CA087538/CA/NCI NIH HHS/United States
- C12292/A11174/CRUK_/Cancer Research UK/United Kingdom
- U10 CA027469/CA/NCI NIH HHS/United States
- R25 CA174664/CA/NCI NIH HHS/United States
- U01 CA116167/CA/NCI NIH HHS/United States
- 12677/CRUK_/Cancer Research UK/United Kingdom
- P30 CA076292/CA/NCI NIH HHS/United States
- P30 CA015083/CA/NCI NIH HHS/United States
- UG1 CA233180/CA/NCI NIH HHS/United States
- 17523/CRUK_/Cancer Research UK/United Kingdom
- 16563/CRUK_/Cancer Research UK/United Kingdom
- U24 CA196067/CA/NCI NIH HHS/United States
- U19 CA148112/CA/NCI NIH HHS/United States
- U10 CA180867/CA/NCI NIH HHS/United States
- U10 CA180838/CA/NCI NIH HHS/United States
- C1287/A10118/CRUK_/Cancer Research UK/United Kingdom
- P30 CA071789/CA/NCI NIH HHS/United States
- U10 CA180822/CA/NCI NIH HHS/United States
- P50 CA136393/CA/NCI NIH HHS/United States
- R01 CA126841/CA/NCI NIH HHS/United States
- 15960/CRUK_/Cancer Research UK/United Kingdom
- 16561/CRUK_/Cancer Research UK/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
